Henri A. Termeer
|Age||Total Calculated Compensation||This person is connected to 296 board members in 16 different organizations across 21 different industries.|
See Board Relationships
Mr. Henri A. Termeer has been Chief Advisor at CANbridge Life Sciences Ltd., since September 26, 2013. Mr. Termeer has been the Chief Executive Officer of Sanofi Biosurgery since December 1985 and has also been its Chairman and President since May 1988 and October 1983, respectively. He is the Founder of Lysosomal Therapeutics Inc. He served as the Chief Executive Officer and President of Genzyme Tissue Repair and Genzyme General since December 1985 and October 1983 ...
55 Cambridge ParkwayPhone: 617-761-8777
Cambridge, Massachusetts 02142
Board Members Memberships*
Executive Director, Member of Strategic Planning & Capital Allocation Committee and Member of Risk Oversight Committee
Chairman, Chief Executive Officer and President
Lead Outside Director, Member of Nominating & Governance Committee and Member of Compensation Committee
Colgate W. Darden Graduate School of Business Administration
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.